BioMed Realty, L.P. to Redeem 3.75% Exchangeable Senior Notes Due 2030
Dec 12 14
BioMed Realty, L.P. has given notice of its intention to redeem all of its outstanding 3.75% Exchangeable Senior Notes due 2030, pursuant to its option under the Indenture. The redemption date is January 30, 2015, and the redemption price is 100% of the principal amount of the Notes plus $1.4583 per $1,000 principal amount of Notes, which is the amount of accrued and unpaid interest thereon to, but excluding, the Redemption Date. As of December 11, 2014, there was approximately $95.7 million aggregate principal amount of the Notes outstanding.
BioMed Realty Issues $400.0 Million Aggregate Principal Amount of 2.625% Senior Notes Due 2019
Apr 23 14
On April 23, 2014, BioMed Realty, L.P., the operating partnership subsidiary of BioMed Realty Trust Inc. (the Company), issued $400.0 million aggregate principal amount of its 2.625% Senior Notes due 2019 (the Notes). The terms of the Notes are governed by a base indenture, dated March 30, 2011, by and among the Operating Partnership, as issuer, the Company, as guarantor, and U.S. Bank National Association, as trustee (the Trustee), as supplemented by a supplemental indenture, dated as of April 23, 2014, by and among the Operating Partnership, the Company and the Trustee (the base indenture and the supplemental indenture, collectively the Indenture). The Indenture contains various restrictive covenants, including limitations on the Operating Partnership's ability to incur additional indebtedness, requirements to maintain a pool of unencumbered assets and requirements to maintain insurance with financially sound and reputable insurance companies. Copies of the base indenture and supplemental indenture, including the form of the Notes and guarantee of the Notes by the Company. The net proceeds from the issuance of the Notes will be approximately $394.5 million, after deducting the underwriters' discounts and the Operating Partnership's estimated offering expenses.